Shiraishi K, Yusa S, Ito M, Nakai K, Yokoyama M
Polymers (Basel). 2019; 9(12).
PMID: 30966010
PMC: 6418968.
DOI: 10.3390/polym9120710.
Hussein Y, Youssry M
Materials (Basel). 2018; 11(5).
PMID: 29702593
PMC: 5978065.
DOI: 10.3390/ma11050688.
Cheetham A, Chakroun R, Ma W, Cui H
Chem Soc Rev. 2017; 46(21):6638-6663.
PMID: 29019492
PMC: 5844511.
DOI: 10.1039/c7cs00521k.
Ramasamy T, Choi J, Cho H, Umadevi S, Shin B, Choi H
Pharm Res. 2014; 32(6):1947-56.
PMID: 25471199
DOI: 10.1007/s11095-014-1588-8.
Dawidczyk C, Russell L, Searson P
Front Chem. 2014; 2:69.
PMID: 25202689
PMC: 4142601.
DOI: 10.3389/fchem.2014.00069.
Poly(2-oxazoline)s as polymer therapeutics.
Luxenhofer R, Han Y, Schulz A, Tong J, He Z, Kabanov A
Macromol Rapid Commun. 2012; 33(19):1613-31.
PMID: 22865555
PMC: 3608391.
DOI: 10.1002/marc.201200354.
Cellular delivery of PEGylated PLGA nanoparticles.
Pamujula S, Hazari S, Bolden G, Graves R, Chinta D, Dash S
J Pharm Pharmacol. 2011; 64(1):61-7.
PMID: 22150673
PMC: 3319145.
DOI: 10.1111/j.2042-7158.2011.01376.x.
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
Daniels T, Bernabeu E, Rodriguez J, Patel S, Kozman M, Chiappetta D
Biochim Biophys Acta. 2011; 1820(3):291-317.
PMID: 21851850
PMC: 3500658.
DOI: 10.1016/j.bbagen.2011.07.016.
Tumor environment changed by combretastatin derivative (Cderiv) pretreatment that leads to effective tumor targeting, MRI studies, and antitumor activity of polymeric micelle carrier systems.
Shiraishi K, Harada Y, Kawano K, Maitani Y, Hori K, Yanagihara K
Pharm Res. 2011; 29(1):178-86.
PMID: 21789726
DOI: 10.1007/s11095-011-0525-3.
Intracellular Distribution-based Anticancer Drug Targeting: Exploiting a Lysosomal Acidification Defect Associated with Cancer Cells.
Ndolo R, Jacobs D, Forrest M, Krise J
Mol Cell Pharmacol. 2011; 2(4):131-136.
PMID: 21274418
PMC: 3026327.
DOI: 10.4255/mcpharmacol.10.18.
Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin.
Kim J, Kabanov A, Bronich T
J Control Release. 2009; 138(3):197-204.
PMID: 19386272
PMC: 2728168.
DOI: 10.1016/j.jconrel.2009.04.019.
Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery.
Osada K, Christie R, Kataoka K
J R Soc Interface. 2009; 6 Suppl 3:S325-39.
PMID: 19364722
PMC: 2690088.
DOI: 10.1098/rsif.2008.0547.focus.
Disposition of drugs in block copolymer micelle delivery systems: from discovery to recovery.
Montazeri Aliabadi H, Shahin M, Brocks D, Lavasanifar A
Clin Pharmacokinet. 2008; 47(10):619-34.
PMID: 18783294
DOI: 10.2165/00003088-200847100-00001.
Therapeutic efficacy of a polymeric micellar doxorubicin infused by convection-enhanced delivery against intracranial 9L brain tumor models.
Inoue T, Yamashita Y, Nishihara M, Sugiyama S, Sonoda Y, Kumabe T
Neuro Oncol. 2008; 11(2):151-7.
PMID: 18755917
PMC: 2718986.
DOI: 10.1215/15228517-2008-068.
The use of ultrasound and micelles in cancer treatment.
Husseini G, Pitt W
J Nanosci Nanotechnol. 2008; 8(5):2205-15.
PMID: 18572632
PMC: 2519605.
DOI: 10.1166/jnn.2008.225.
Ultrasonic-activated micellar drug delivery for cancer treatment.
Husseini G, Pitt W
J Pharm Sci. 2008; 98(3):795-811.
PMID: 18506804
PMC: 2635419.
DOI: 10.1002/jps.21444.
Micelles and nanoparticles for ultrasonic drug and gene delivery.
Husseini G, Pitt W
Adv Drug Deliv Rev. 2008; 60(10):1137-52.
PMID: 18486269
PMC: 2490710.
DOI: 10.1016/j.addr.2008.03.008.
Anti-tumor effect of all-trans retinoic acid loaded polymeric micelles in solid tumor bearing mice.
Chansri N, Kawakami S, Yokoyama M, Yamamoto T, Charoensit P, Hashida M
Pharm Res. 2007; 25(2):428-34.
PMID: 17665288
DOI: 10.1007/s11095-007-9398-x.
Micellar nanocarriers: pharmaceutical perspectives.
Torchilin V
Pharm Res. 2006; 24(1):1-16.
PMID: 17109211
DOI: 10.1007/s11095-006-9132-0.
Ultrasonic drug delivery--a general review.
Pitt W, Husseini G, Staples B
Expert Opin Drug Deliv. 2005; 1(1):37-56.
PMID: 16296719
PMC: 1361256.
DOI: 10.1517/17425247.1.1.37.